Medicare coverage of obesity medications could drive a substantial rise in healthcare spending, according to a new study. A microsimulation model published in JAMA Health Forum projected that Medicare ...

A Howard County man is suing Novo Nordisk, alleging Ozempic caused him to go blind after using the drug to treat diabetes. He seeks damages in court.

While the drugs have grown in popularity among doctors and patients, they are generally too expensive for most people to ...

Experts share why a diet rich in plant-based, nutrient-dense foods is key to staying healthy when using medications that curb ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

Wegovy's launch in Thaliand comes nearly a month after Eli Lilly launched its obesity management drug Mounjaro in India at ...

Weight loss drugs like Ozempic, Zepbound and Wegovy are surging in popularity. Now, a new pill from Eli Lilly has taken a ...

HSBC analyst warns of a downside in Eli Lilly stock to $700. Rajesh Kumar cited 'valuation' as his number 1 concern.

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

All these drugs are very effective and they’ve become a game changer for people who need to lose weight. Get on the drug, eat ...

The weight-loss drugs have grown in popularity, but are generally too expensive for most people to afford without insurance ...